Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCH) announces a new version of Hippocrates AI Health Information System #ArtificialIntelligence

 Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCH) announces a new version of Hippocrates AI Health Information System #ArtificialIntelligence

 

San Diego, CA, July 28, 2022 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), announced that it is releasing a new version of its Hippocrates web application; an AI based health information system that aims to provide health information. Hippocrates is a machine learning driven health content provider that is targeted for personal and professional use. Users may provide symptoms, ask medical questions and describe conditions in order to get first line health information about possible illness, including known medication and treatments. Hippocrates new version now incorporates governmental and professional accredited data resources, among them are the CDC (Center of Dieses Control and Prevention - Centers for Disease Control and Prevention (cdc.gov), and other health resources data as references. The new release also uses Avant! AI engine to provide intelligent internet search, providing answers for general or specific health related questions. GBT is targeting Hippocrates to assist professional physicians, hospitals and clinics in specific domains to provide medical information and diagnostics assistance. The system is designed to provide ongoing training within the medical professional’s experience to gain robust knowledge over time, in addition to automatic updates of governmental resources and medical documentation. The service is also available for adults (18+) under a disclaimer and is not intended to replace a human physician. GBT plans to seek partners within the medical field including clinics or hospitals with the goal of creating a domain specific health advisory system to assist with diagnostics and recommended treatments. Hippocrates AI system is available to provide information for general health related questions via its web application at www.hmd.care.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2022/07281Hippocrates-AI-Health-Information-System.asp

 

"We are pleased to announce Hippocrates health advisory system new release, an AI driven information source for every day users" stated Danny Rittman, GBT’s CTO. "This is only one of the many possible implementations of our core Avant! AI technology. The AI system is targeted to understand a user’s question, analyzing the information and providing a targeted response. Hippocrates new release is equipped with an initial vast amount of health-related data and is situated to cognitively grow its knowledge base over time, learning from its own experiences or by training, the same way a human does. We invested vast efforts with the new release, incorporating professional, accredited data from governmental and medical documentation resources. The current release is aimed to provide a first line of health-related information. In addition, it offers Avant! intelligent internet search to provide answers and information for health-related questions. The system is not aiming to replace physicians but to provide a first line health information and guidelines. We also plan to seek clinics and hospitals as partners to provide an expert assistant in specific domains, for example cardiology or pediatrics expertise. The Hippocrates system can become a specific domain expert by professional resources ongoing training and experience. This type of system can be also useful to provide health related assistance and advising for remote locations, and for general use. Hippocrates includes mobile application synchronized with the web application making it available anywhere around the world. We plan to continue the development of the Hippocrates system, training it with more health-related information and providing it with more advanced capabilities, making it a comprehensive, personal health resource”.

 

IMPORTANT:

Hippocrates system does not provide medical advice. It is aimed for health-related informational purposes only. It doesn’t substitute professional medical advice, diagnosis or treatment. Never ignore professional medical advice or diagnostics in seeking evaluation or treatment due of material provided by Hippocrates system. If you think you may experience a medical emergency, immediately dial 911 or go to the nearest emergency room.

 

Avant! - AI set of algorithms enables GBT to potentially provide users with features and services, including statistical information, and other interactive and non-interactive features, all of which may be updated, deleted, or otherwise modified from time to time at the discretion of the GBT. The Hippocrates Platform will be provided "as is" and GBT assumes no responsibility in connection with its use and the content provided therein.

 

THE GBT AND AVANT SITES AND ANY SERVICES, CONTENT OR INFORMATION CONTAINED ON OR PROVIDED BY GBT IS PROVIDED ON AN "AS IS" BASIS. GBT DOES NOT MAKE ANY EXPRESS OR IMPLIED WARRANTIES, REPRESENTATIONS OR ENDORSEMENTS WHATSOEVER (INCLUDING WITHOUT LIMITATION WARRANTIES OF TITLE OR NONINFRINGEMENT, OR THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE) WITH REGARD TO THE SERVICE OR ANY MERCHANDISE, INFORMATION OR SERVICE PROVIDED THROUGH THE SERVICE. IN ADDITION, GBT DOES NOT GUARANTEE THAT USE OF ITS SITES WILL BE FREE FROM TECHNOLOGICAL DIFFICULTIES INCLUDING, BUT NOT LIMITED TO, UNAVAILABILITY OF INFORMATION, DOWNTIME, SERVICE DISRUPTIONS, VIRUSES OR WORMS, AND YOU UNDERSTAND THAT YOU ARE RESPONSIBLE FOR IMPLEMENTING SUFFICIENT PROCEDURES AND CHECKPOINTS TO SATISFY YOUR PARTICULAR REQUIREMENTS FOR ACCURACY OF DATA INPUT AND OUTPUT.

 

THE USE OF THE SITE IS ENTIRELY AT YOUR OWN RISK, AND IN NO EVENT SHALL GBT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY, PUNITIVE, OR ANY OTHER MONETARY OR OTHER DAMAGES, FEES, FINES, PENALTIES, OR LIABILITIES ARISING OUT OF OR RELATING IN ANY WAY TO THIS SERVICE, OR SITES ACCESSED THROUGH THIS SERVICE, AND/OR CONTENT OR INFORMATION PROVIDED HEREIN. YOUR SOLE AND EXCLUSIVE REMEDY FOR DISSATISFACTION WITH THE SERVICE IS TO STOP USING THE SERVICE. USER HEREBY ACKNOWLEDGES THAT THIS PARAGRAPH SHALL APPLY TO ALL CONTENT, MERCHANDISE AND SERVICES AVAILABLE THROUGH THE SITE.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
GBT Technologies Inc.

Media: press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp 

 

 

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

Breaking #Tech #Stock News: Wearable Health Solutions Inc. (OTC Pink: $WHSI) Expects to Launch its Ecosystem of New Products in August 2022; @WHSI_

 Breaking #Tech #Stock News: Wearable Health Solutions Inc. (OTC Pink: $WHSI) Expects to Launch its Ecosystem of New Products in August 2022; @WHSI_

 

NEWPORT BEACH, CA - July 14, 2022 (Investorideas.com Newswire) Wearable Health Solutions Inc. (OTC PINK:WHSI) ("Wearable Health Solutions Inc" or the "Company"), today announced that "The company expects to launch its new ecosystem of products and services to its dealer and vendor networks in August of 2022", stated Peter Pizzino President. "The product offering includes the anticipated 4G device, docking station, vital wrist bands and accessories. A variety of bundled features of the new 4G mobile medical alarm are available to users to suit personal needs and priorities".

                                                        

Read this news, featuring WHSI in full at https://www.investorideas.com/news/2022/technology/07141WHSI-New-Products.asp

Additionally, the company has filed an application to up-list its common stock for quotation on the OTC: QB trading platform; when approved, it may provide investors, funds, brokers, and institutions greater access to participate in the trading of its company's common stock.

The company intends to access the capital markets so it may consider financing alternatives in various forms for $5.0 million. This will enable the company to fund and expedite the launch of its next generation mobile medial device, including, but limited to its Lone Worker Program initiative scheduled for release in the summer of 2022. Moreover, to fund the company's launch into the $30+ billion market of Virtual Care and remote patient monitoring solutions.

 

In addition, the company has retained International Monetary (IM), a full-service merchant banking and strategic advisory firm located in Newport Beach, California. M.B. (Blaine) Riley, III, Managing Director and President of IM, stated, "We will introduce the company to our nationwide brokerage network comprised of broker-dealers and investment banks focused on the micro-cap and small-cap sectors, while on the investor relations side, we will direct a series of initiatives to the investment community for enhancing shareholder value and market awareness".

 

Recently the company updated its websites at:

wearablehealthsolutions.com; ihelpalarm.com; 1800medalert.com; wearablehealthsolutions.com/investor-relations; reflecting corporate, product, DTC, and further investor relations references.

 

About Us:

WHSI is a manufacturer of PERS (Personal Emergency Response Systems ("PERS")) devices, and in the rapidly growing medical alarm device and eHealth sector. As such, we provide innovative wearable healthcare products and services to dealers and distributors across the globe. Our management team has over 30 years in the business, beginning with the launch of the MediPendant™, the first medical alarm device that enabled the user to speak and listen to the emergency response operator directly through the pendant. WHSI will be launching its latest PERS device, the iHelp Max in the Summer 2022. The iHelp Max is a 4G cellular PERS device with advanced features such as fall detection, geo-fencing, AI utilizing Google Assistant and Alexa, notifications, daily check-ins, and medication reminders, that are sold directly to dealers and distributors in the U.S and around the world. Further to the launch of the iHelp Max, the company is developing additional features for the device that include RPM (Remote Patient Monitoring). WHSI's advanced medical alarm technology platform enables remote monitoring and data collection of essential vital signs in real-time and with historical values via Bluetooth, NFC, and WIFI technology. Our RPM solution includes real time monitoring of vital signs that will be stored in the cloud to enable viewing of historical data as well as identify potential health issues before they become catastrophic events. WHSI is offering two distinct RPM paths to market, Direct to Consumer and Enterprise solutions to improve the quality of care to our loved ones and users while lowering costs for healthcare companies.

 

Forward-Looking Statements

Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Wearable Health Solutions and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to (i) Wearable Health Solutions ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Wearable Health Solution's ability to maintain existing, and secure additional, contracts with users of its solutions; (iii) Wearable Health Solution's ability to successfully expand in existing markets and enter new markets; (iv) Wearable Health Solution's ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Wearable Health Solution's business; (viii) changes in government licensing and regulation that may adversely affect Wearable Health Solution's business; (ix) the risk that changes in consumer behavior could adversely affect Wearable Health Solution's business; (x) Wearable Health Solution's ability to protect its intellectual property; (xi) local, industry and general business and economic conditions. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent quarterly report on filed by Wearable Health Solutions with the Securities and Exchange Commission. Wearable Health Solutions anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Wearable Health Solutions assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

 

Contact: www.wearablehealthsolutions.com

2901 W. Pacific Highway Suite 200,
Newport Beach CA 92663
Tel: 949-270-7460

 

SOURCE: Wearable Health Solutions, Inc.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Wearable Health Solutions, Inc. (WHSI) is a paid news and social media company on Investorideas starting June 6 ( 3500 monthly ) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

New #Stocks and #TradingIdeas for #Mining, #Biotech, #eSport and #PlantBased (TSXV: $SGO.V) (TSXV: $STS.V) (TSXV: $SR.V) (NASDAQ: $ATHE) (OTCQX: $EMMA) (CSE: $XONE.C) (CSE: $PNGA.C)

 New #Stocks and #TradingIdeas for #Mining, #Biotech, #eSport and #PlantBased (TSXV: $SGO.V) (TSXV: $STS.V) (TSXV: $SR.V) (NASDAQ: $ATHE) (OTCQX: $EMMA) (CSE: $XONE.C) (CSE: $PNGA.C)

 

 

 

 

Vancouver, Kelowna, Delta, BC, July 8, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Biotech, eSport and Plant-Based. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2022/main/07081Stocks.asp

 

The newest mining companies have operations world-wide, including in Latin America and are involved in precious metals and minerals including graphite and vanadium.

 

The latest biotech companies are involved in treatments for Parkinson’s, sickle cell, central nervous system, respiratory, metabolic and infectious diseases, respectively.

 

The newest eSport company is involved in competitive playing of video games by teams for cash prizes, while the latest plant-based/vegan company is ‘Vancouver’s own vegan food company.’

 

New Stocks added to the Mining Stocks List:

Sonoro Gold Corp (TSXV:SGO) is a publicly listed exploration and development company holding the near development stage Cerro Caliche project and the exploration stage San Marcial properties in Sonora State, Mexico. The Company has highly experienced operational and management teams with proven track records for the discovery and development of natural resource deposits.

 

South Star Battery Metals Corp (TSXV:STS) is a Canadian battery metals project developer focused on the selective acquisition and development of near-term production projects in the Americas. South Star’s Santa Cruz Graphite Project, located in Southern Bahia, Brazil is the first of a series of industrial and battery metals projects that will be put into production. Brazil is the second-largest graphite-producing region in the world with more than 80 years of continuous mining. Santa Cruz has at-surface mineralization in friable materials, and successful large-scale pilot-plant testing (>30t) has been completed. The results of the testing show that approximately 65% of Cg concentrate is +80 mesh with good recoveries and 95%-99% Cg. With excellent infrastructure and logistics, South Star is carrying its development plan towards Phase 1 production projected in Q2 2023. South Star’s next project in the development pipeline is a project in Alabama located in the middle of a developing electric vehicle, aerospace and defence hub in the southeastern United States. The Project is a historic mine active during World Wars I & II. Trenching, sampling, analysis and preliminary metallurgic testing has been completed. The testing indicated a traditional crush/grind/flotation concentration circuit achieved grades of approximately 96-97% with approximately 86% recoveries. South Star is executing on its plan to create a multi-asset, diversified battery metals company with near-term operations in strategic jurisdictions.

 

Stallion Gold Corp. (TSXV:STUD) is a mineral exploration company focused on the exploration of precious metals and critical minerals. Stallion Gold is using modern exploration techniques to explore historical and new mineral targets on its expansive land package in Idaho and Nevada. A strong management team brings expertise in both the capital markets and the technical talent for acquiring early-stage property with highly prospective targets.

 

Strategic Resources Inc. (TSXV:SR) is a Vancouver, Canada-based mineral exploration and development company focused on vanadium projects in Finland. The Company is primarily focused on its flagship Mustavaara vanadium-iron-titanium project in Finland. The Company continues to evaluate new opportunities that are related to the electrification of the economy.

 

Stuhini Exploration Ltd. (TSXV:STU) is a mineral exploration company focused on the exploration and development of it's base and precious metal properties in western Canada. The Company's portfolio of exploration properties includes: its flagship, the Ruby Creek Property, located approximately 20 km east of Atlin, BC; the Que Project located approximately 70 km north of Johnson's Crossing in the Yukon; the South Thompson Project located approximately 35 km northwest of Grand Rapids, Manitoba; and the Big Ledge Property located approximately 57 km south of Revelstoke, BC.

 

Summa Silver Corp. (TSXV:SSVR) is a Canadian junior mineral exploration company. The Company owns a 100% interest in the Hughes property located in central Nevada and has an option to earn 100% interest in the Mogollon property located in southwestern New Mexico. The Hughes property is host to the high-grade past-producing Belmont Mine, one of the most prolific silver producers in the United States between 1903 and 1929. The Mogollon property is the largest historic silver producer in New Mexico. Both properties have remained inactive since commercial production ceased and neither have seen modern exploration prior to the Company's involvement.

 

Sable Resources Ltd (TSXV:SAE) is a well-funded junior grassroots explorer focused on the discovery of Tier-One new precious metal and copper projects through systematic exploration in endowed terranes located in favorable, established mining jurisdictions. Sable's main focus is developing its large portfolio of new greenfields projects to resource level. Sable is actively exploring the San Juan Regional Program (163,969 ha) incorporating the Don Julio, El Fierro, La Poncha, and Los Pumas Projects in San Juan Province, Argentina; and the Mexico Regional Program (1.16Mha in application, 39,000ha titled) incorporating the Vinata and El Escarpe projects.

 

Gold Line Resources Ltd. (TSXV:GLDL) is focused on acquiring mineral properties with exceptional exploration potential in the most prolific gold-producing regions of Sweden and Finland. Gold Line is working in two of the world's top mining jurisdictions and emerging exploration frontiers due to their strong mineral endowment, stable tenure, straightforward permitting, favourable tax regime and supportive geopolitical landscape. Gold Line currently holds a prospective portfolio of gold exploration projects in Sweden and Finland. In Sweden projects are located in the Gold Line Mineral Belt and Skellefteå Belt of north-central Sweden, and the Mjøsa-Vänern Belt in southwest Sweden. In Finland Gold Line holds the entire underexplored Oijärvi Greenstone Belt located in northern Finland.

 

Gold Royalty Corp. (NYSE:GROY) is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. Its mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for its investors. Gold Royalty's diversified portfolio currently consists primarily of royalties on gold properties located in the Americas.

 

Gold Terra Resource Corp. (TSXV:YGT) The Yellowknife City Gold (YCG) project encompasses 800 sq. km of contiguous land immediately north, south and east of the City of Yellowknife in the Northwest Territories. Through a series of acquisitions, Gold Terra controls one of the six major high-grade gold camps in Canada. Being within 10 kilometres of the City of Yellowknife, the YCG is close to vital infrastructure, including all-season roads, air transportation, service providers, hydro-electric power, and skilled tradespeople. Gold Terra is currently focusing its drilling on the prolific Campbell shear, where 14 Moz of gold has been produced, and most recently on the Con Mine Option claims immediately south of the past producing Con Mine (1938-2003). The YCG lies on the prolific Yellowknife greenstone belt, covering nearly 70 kilometres of strike length along the main mineralized shear system that host the former-producing high-grade Con and Giant gold mines. The Company's exploration programs have successfully identified significant zones of gold mineralization and multiple targets that remain to be tested which reinforces the Company's objective of re-establishing Yellowknife as one of the premier gold mining districts in Canada.

 

Scottie Resources Corp. (TSXV:SCOT) owns a 100% interest in the high-grade, past-producing Scottie Gold Mine and Bow properties and has the option to purchase a 100% interest in Summit Lake claims which are contiguous with the Scottie Gold Mine property. Scottie also owns 100% interest in the Georgia Project which contains the high-grade past-producing Georgia River Mine, as well as the Cambria Project properties and the Sulu property. Altogether Scottie Resources holds more than 52,000 ha of mineral claims in the Stewart Mining Camp in the Golden Triangle. The Company's focus is on expanding the known mineralization around the past-producing mines while advancing near mine high-grade gold targets, with the purpose of delivering a potential resource. The Company's focus is on expanding the known mineralization around the past-producing mine while advancing near mine high-grade gold targets, with the purpose of delivering a potential resource. All of the Company's properties are located in the area known as the Golden Triangle of British Columbia which is among the world's most prolific mineralized districts.

 

Silver Viper Minerals Corp. (TSXV:VIPR) is a Canadian-based junior mineral exploration company focused on precious metals exploration in the northwestern Mexican state of Sonora. The Company currently operates the La Virginia Gold-Silver Project. Silver Viper has 100% ownership of the La Virginia concessions acquired from the most recent operator, Pan American Silver Corp., and has an option to acquire a 100% interest in the Rubi-Esperanza group of claims internal to those concessions. Silver Viper is under management provided by the Belcarra Group, which is comprised of highly qualified mining professionals.

 

Silver X Mining Corp (TSXV:AGX) is a Canadian silver mining company with assets in Peru. The Company's flagship asset is the Nueva Recuperada silver, gold, lead, zinc and copper project located in Huancavelica, Peru, 10 km north-northwest of the Nueva Recuperada polymetallic concentrate plant.

 

Sitka Gold Corp (CSE:SIG) is a mineral exploration company headquartered in Canada that is fully funded for its planned 2022 exploration programs with the recent completion of a $4.69 million financing. The Company is managed by a team of experienced industry professionals and is focused on exploring for economically viable mineral deposits with its primary emphasis on gold, silver and copper mineral properties of merit. Sitka currently has an option to acquire a 100% interest in the RC, Barney Ridge, Clear Creek and OGI properties in Yukon and the Burro Creek Gold property in Arizona. Sitka owns a 100% interest in its Alpha Gold property in Nevada, it's Mahtin Gold property in the Yukon and it's Coppermine River project in Nunavut.

 

SKRR Exploration Inc. (TSXV:SKRR) is a Canadian-based precious metal explorer with properties in British Columbia and Saskatchewan – some of the world's highest ranked mining jurisdictions. The primary exploration focus is on the Trans-Hudson Corridor in Saskatchewan in search of world class precious and base metal deposits. The Trans-Hudson Orogen – although extremely well known in geological terms has been significantly under-explored in Saskatchewan.

 

Snowline Gold Corp. (CSE:SGD) is a Yukon Territory focused gold exploration company with a seven-project portfolio covering >127,000 ha. The Company is exploring its flagship >85,000 ha Einarson and Rogue gold projects in the highly prospective yet underexplored Selwyn Basin. Snowline's project portfolio sits within the prolific Tintina Gold Province, host to multiple million-ounce-plus gold mines and deposits including Kinross' Fort Knox mine, Newmont's Coffee deposit, and Victoria Gold's Eagle Mine. The Company's first-mover land position and extensive database provide a unique opportunity for investors to be part of multiple discoveries and the creation of a new gold district.

 

Scout Minerals Corp. (CSE:SCTM) is a junior mining company engaged in the acquisition, exploration and development of mineral properties.  The company is currently focused on the McKinney Property located in the Osoyoos mining division of British Columbia.

 

New Stocks added to the Biotech Stocks List:

Alterity Therapeutics (NASDAQ:ATHE; ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company's lead asset, ATH434, has the potential to treat various Parkinsonian disorders. Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA.

 

Emmaus Life Sciences, Inc. (OTCQX:EMMA) is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. The company currently markets and sells Endari® (L-glutamine oral powder), indicated to reduce the acute complications of sickle cell disease in adults and children 5 years and older, in the U.S. and in the United Arab Emirates, or U.A.E., and is pursuing marketing authorization for Endari® in the Kingdom of Saudi Arabia, Bahrain and other Gulf Cooperation Council countries. The company is also engaged in the discovery and development of innovative treatments and therapies for certain rare and orphan diseases as well as those affecting larger populations, such as diverticulosis and certain cancers.

 

Reviva Pharmaceuticals (NASDAQ:RVPH) is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva’s pipeline currently includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.

 

Poolbeg Pharma PLC (OTCQB:POLBF; LSE:POLB) is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which aims to develop multiple products faster and more cost effectively than the conventional biotech model. The Company, headquartered in London, is led by a team with a track record of creation and delivery of shareholder value and aspires to become a "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire. The Company is targeting the growing infectious disease market. In the wake of the COVID-19 pandemic, infectious disease has become one of the fastest growing pharma markets and is expected to exceed $250bn by 2025. With its initial assets from Open Orphan plc, an industry leading infectious disease and human challenge trials business, Poolbeg has access to knowledge, experience, and clinical data from over 20 years of human challenge trials. The Company is using these insights to acquire new assets as well as reposition clinical stage products, reducing spend and risk. Amongst its portfolio of exciting assets, Poolbeg has a small molecule immunomodulator for severe influenza (POLB 001); a first-in-class, intranasally administered RNA-based immunotherapy for respiratory virus infections (POLB 002); and a vaccine for Melioidosis (POLB 003). The Company is also developing an oral vaccine delivery platform and is progressing two artificial intelligence (AI) drug discovery programmes to accelerate the power of its human challenge model data and biobank.

 

New Stocks added to the eSport Stocks List:

X1 Esports and Entertainment Ltd. (CSE: XONE) is an esports portfolio company which owns and operates a growing esports franchise, RixGG. The business of the Company is the competitive playing of video games by teams for cash prizes, and operations ancillary to such competition, such as merchandising and the hosting of tournaments.

 

New Stocks added to the Plant-Based Stocks List:

Pangea Natural Foods Inc. (CSE:PNGA) Founded in April 2021 by Pratap Sandu, Pangea Natural Foods Inc. is Vancouver’s own vegan food company. Pangea Natural Foods has partnered with world renowned food scientists to formulate its high-quality food product and is set to launch its first product, the “Plant-based Patties.” Pangea Foods offers a revolutionary Plant-based Patty free of GMO ingredients, fillers, antibiotics, hormones, and bioengineered ingredients. Standing by their brand “Powered by Plants,” Pangea Foods plans for a wide array of vegan food products in the near future thanks to its CFIA and FDA-approved production facility.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411